Explainable AI for computational pathology identifies model limitations and tissue biomarkers

HIPPO enables detection of model failures that standard metrics miss: In breast metastasis detection, the explainability method uncovered critical model limitations that were not visible through conventional performance evaluation or attention-based visualization methods, highlighting that accuracy scores alone may mask important safety issues in clinical AI systems.

Counterfactual analysis provides more reliable model interpretation than existing methods: By systematically removing or adding tissue regions to create modified images, HIPPO outperformed attention-based approaches in identifying which tissue elements actually influence predictions, offering a more rigorous and trustworthy way to understand how AI models make decisions in pathology.

Explainability can support hypothesis generation for personalized medicine: The method facilitated identification of melanoma patients who may benefit from immunotherapy through systematic analysis of tissue biomarkers, demonstrating that interpretable AI can contribute to clinical insights beyond just making predictions.

Bias and limitations can be systematically identified and quantified: HIPPO enables "quantitative hypothesis testing, bias detection, and performance evaluation that extend beyond standard metrics," providing pathologists and clinicians with concrete evidence of where and why models may fail rather than treating them as black boxes.

Explainability is essential for clinical adoption of deep learning: The paper emphasizes that the "opaque decision-making processes" of standard deep learning models "limit trust and clinical adoption," suggesting that interpretability methods are not optional add-ons but necessary components for responsible deployment in healthcare.